Protocol A8121014: A Phase 2, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Filibuvir Plus Pegylated Interferon Alfa-2A and Ribavirin in Treatment Naive, HCV Genotype 1 Infected subjects
- Flamm, Steven L (PD/PI)
- Ganger, Daniel R (Co-Investigator)
Project: Research project